Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00894465 · ClinicalTrials.gov registry record · NA

Midazolam Effect in Children Undergoing Voiding Cystourethrogram (VCUG)

A NA study, sponsored by Washington University School of Medicine.

Terminated
Registry status
NA
Development phase
44
Enrollment target

NCT00894465: Clinical Trial NA study, sponsored by Washington University School of Medicine.

NCT00894465 is a NA study that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 44 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00894465, a NA study, was terminated before completion, sponsored by Washington University School of Medicine.

TERMINATED
Registry status
NA
Development phase
44 participants
Enrollment target

Study Summary

The purpose of this research is to validate the common administration of oral midazolam to children prior to voiding cystourethrogram (VCUG) to see if this will significantly decrease children's anxiety and make the experience less traumatic.

Primary Outcome

The modified Yale preoperative scale consists of 5 categories (activity, vocalizations, emotional expressivity, state of apparent arousal, and use of parents). Four of the five categories are scored between 1-4 points and one of the categories is scored from 1-6 points. The scores are divided by their number of possible points in their respective category and multiplied by 20 to get the final anxiety score which ranges from 20 to 100. Low numbers represent low anxiety and higher numbers represen

Interventions

  • DRUG placebo
  • DRUG midazolam

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2006-08
Est. Completion 2009-08
Phase NA

Why NCT00894465 stopped before completion

NCT00894465 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.

NCT00894465 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00894465 about?

NCT00894465 is a clinical study titled "Midazolam Effect in Children Undergoing Voiding Cystourethrogram (VCUG)". The purpose of this research is to validate the common administration of oral midazolam to children prior to voiding cystourethrogram (VCUG) to see if this will significantly decrease children's anxiety and make the experience less traumatic.

What is the current status of trial NCT00894465?

This trial is currently terminated. It is a NA study. The enrollment target is 44 participants. The study started on 2006-08. Estimated completion is 2009-08.

What interventions are being tested in trial NCT00894465?

The interventions under investigation include: placebo (DRUG), midazolam (DRUG).

Who is sponsoring clinical trial NCT00894465?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00894465's enrollment target sits among peer trials

44 1423rd of 2000 higher than 566 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02323945 · 44 participants · NA

    Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury

  • NCT03093909 · 44 participants · Phase 1

    Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases

  • NCT03104491 · 44 participants · Phase 1

    Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia

  • NCT03781765 · 44 participants · Phase 4

    Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00894465, the US trial registry maintained by the National Library of Medicine. NCT00894465 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.